Mutual Funds › MFIC › Categories › Sectoral/Thematic › Healthcare & pharma

Sectoral/Thematic: Healthcare & pharma

At least 80% in a particular sector or theme. Shown here: the 19 schemes MFIC groups under “Healthcare & pharma” (a grouping from scheme names, not an AMFI category). This page lists every Sectoral/Thematic scheme in this group (Direct plan, growth option) with its returns, rolling-return consistency and risk, calculated from AMFI NAVs as of 1 Oct 2026.

Schemes
19
Median 1Y return
17.5%
Median 3Y CAGR
20.8%
Median 5Y CAGR
15.3%
Median 3Y rolling
21.4%
Median max DD 5Y
−18.8%
Market context from Integrato Market Intelligence

Schemes in this group invest mainly in the markets below, which are also close to how many of them are benchmarked. Where those markets stand today:

26,311.55 −0.48%
NSE close, 1 Oct 2026
  • P/E 40.7: higher than 94% of days since 2023 (median 34.1)
  • 1Y +21.5% · 3Y +19.9% p.a. · 5Y +13.1% p.a. (index fund NAV, after costs)
  • −3.2% from its 52-week high
16,095.55 −0.26%
NSE close, 1 Oct 2026
  • P/E 41.9: higher than 79% of days since 2023 (median 38.5)
  • 1Y +12.4% · 3Y +18.3% p.a. · 5Y n/a p.a. (index fund NAV, after costs)
  • −5.0% from its 52-week high (proxy NAV)
21,857.75 −0.97%
NSE close, 1 Oct 2026
  • P/E 21.6: higher than 1% of days since 2023 (median 24.2)
  • 1Y −3.9% · 3Y +8.9% p.a. · 5Y +8.6% p.a. (index fund NAV, after costs)
  • −9.3% from its 52-week high

Index levels and P/E: NSE daily index closing values; gold and silver: IBJA rates; returns: growth NAV of an index fund or ETF tracking the market (AMFI), so they are after that fund's costs. Context only: a market's level or valuation does not tell you how any scheme will perform. Explore all markets.

Sectoral/Thematic: Healthcare & pharma schemes, Direct plans alphabetical · 19 schemes
SchemeNAV (₹)AUM (₹ cr)TER1Y3Y CAGR5Y CAGR3Y rolling median3Y rolling worst3Y beat-rateStd devMax DD 5YHistory
Aditya Birla Sun Life Pharma and Healthcare Fund
Aditya Birla Sun Life Mutual Fund
39.621,0781.07%17.5%20.1%14.0%19.9%12.1%66%15.3%−20.2%7.2 y
Bajaj Finserv Healthcare Fund
Bajaj Finserv Mutual Fund
11.734050.90%21.0%n/an/an/an/an/an/an/a1.8 y
Bandhan Healthcare Fund
Bandhan Mutual Fund
11.07n/a1.31%n/an/an/an/an/an/an/an/a0.8 y
Baroda BNP Paribas Health and Wellness Fund
Baroda BNP Paribas Mutual Fund
10.684871.47%11.9%n/an/an/an/an/an/an/a1.3 y
DSP Healthcare Fund
DSP Mutual Fund
49.803,7500.75%15.6%20.7%15.2%22.8%15.0%72%15.1%−20.5%7.8 y
HDFC Pharma and Healthcare Fund
HDFC Mutual Fund
21.983,5011.03%26.6%30.2%n/an/an/an/a16.1%n/a3.0 y
ICICI Prudential Healthcare Fund
ICICI Prudential Mutual Fund
45.926,8611.32%8.0%21.1%15.6%25.2%14.7%72%16.2%−17.8%8.2 y
Invesco India Pharma and Healthcare Fund
Invesco Mutual Fund
9.57n/a3.30%n/an/an/an/an/an/an/an/a0.1 y
ITI Pharma and Healthcare Fund
ITI Mutual Fund
19.432660.89%12.4%18.9%n/a21.4%17.6%100%16.5%n/a4.9 y
Kotak Healthcare Fund
Kotak Mahindra Mutual Fund
17.608351.04%28.8%n/an/an/an/an/an/an/a2.8 y
LIC MF Healthcare Fund
LIC Mutual Fund
36.41991.38%13.8%20.9%n/a22.6%20.9%100%16.1%n/a3.2 y
Mirae Asset Healthcare Fund
Mirae Asset Mutual Fund
51.143,4940.62%20.3%21.8%15.3%23.3%14.3%70%16.0%−18.5%8.2 y
Nippon India Pharma Fund
Nippon India Mutual Fund
628.419,1661.00%12.4%17.6%13.5%19.9%-1.3%70%14.8%−19.1%13.7 y
PGIM India Healthcare Fund
PGIM India Mutual Fund
12.241301.00%25.7%n/an/an/an/an/an/an/a1.8 y
quant Healthcare Fund
quant Mutual Fund
18.694311.56%18.7%20.2%n/a21.6%19.7%100%18.1%n/a3.2 y
SBI HEALTHCARE OPPORTUNITIES FUND
SBI Mutual Fund
584.625,8701.01%20.2%22.8%17.8%21.0%-8.9%72%14.4%−17.7%13.7 y
Tata India Pharma & Healthcare Fund
Tata Mutual Fund
38.06n/a1.07%7.9%18.3%14.0%21.2%-3.4%70%16.5%−16.8%10.8 y
UTI - Healthcare Fund
UTI Mutual Fund
378.651,4301.34%16.7%22.5%15.3%17.9%-6.5%68%15.9%−21.1%13.7 y
WhiteOak Capital Pharma and Healthcare Fund
WhiteOak Capital Mutual Fund
17.229271.06%22.1%n/an/an/an/an/an/an/a2.6 y

Returns are from NAVs (after expenses, before tax); 3Y and 5Y are annualised. Rolling figures use every business-day start date in the scheme's history; beat-rate is the share of 3-year windows ahead of Nifty 500 (proxy: Motilal Oswal Nifty 500 Index Fund, price return). Std dev is annualised over 36 months. AUM is the whole scheme (all plans) and TER is for the plan shown, both as disclosed to AMFI. "n/a" means the scheme's history is too short or the data is still loading. Listed alphabetically; no order of preference is implied. Full definitions: MFIC methodology.

Other categories
Reviewing your own mutual fund portfolio?
Integrato's team can walk you through how your current schemes have behaved, using the same data shown here. Integrato is an AMFI-registered Mutual Fund Distributor.
Get the Market Pulse by email every Monday

Every Monday: index benchmarks and the median 1-month and 1-year return of every equity category, plus broad equity, hybrid and debt figures. Calculated from AMFI NAVs. Free; unsubscribe from any email.

We email a confirmation link first. Integrato is an AMFI-registered Mutual Fund Distributor (ARN-173155); these emails are information, not recommendations.

Data & disclosure. Source: AMFI daily NAV file (portal.amfiindia.com) and historical NAVs via mfapi.in; calculations by MFIC. Data as of 1 Oct 2026. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance may or may not be sustained in future. This page is for research and education only and is not investment advice or a recommendation. Integrato Financial Services Pvt. Ltd. is an AMFI-registered Mutual Fund Distributor (ARN-173155).